DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMIR. Mazza,M. Spina,C. Califano,F. Gaudio, M. Carella,U. Consoli,F. Palombi,M. Musso,A. Pulsoni,S. Kovalchuk,M. Bonfichi, F. Ricci,A. Fabbri,A. Liberati,M. Rodari,L. Giordano,M. Balzarotti,A. Gallamini,U. Ricardi,S. Chauvie,F. Merli,C. Carlo-Stella, A. SantoroHematological Oncology（2019）引用 0|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
